SCHEMBL15538448

SCHEMBL15538448

CC(C)(F)CN1CCC(COc2ccc(-c3ccc(C(=O)O)c(F)c3)cc2F)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.43
CHRM2 P08172 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
SCN7A Q01118 3/20 0.42
SSTR5 P35346 1/20 0.42
KCNH2 Q12809 1/20 0.42
RARA P10276 1/20 0.41
RARB P10826 1/20 0.41
SCN5A Q14524 2/20 0.41
PPARD Q03181 4/20 0.40
FFAR1 O14842 3/20 0.40
FFAR4 Q5NUL3 3/20 0.40
SYK P43405 1/20 0.40
GPR119 Q8TDV5 2/20 0.40
RBP4 P02753 1/20 0.39
SCN9A Q15858 1/20 0.39
PPARA Q07869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15538764 0.92 CHRM4 (0.40) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15539260 0.91 XDH (0.46) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL16757956 0.90 RARB (0.44) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15538824 0.90 CHRM2 (0.42) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15538445 0.90 RARA (0.51) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15540445 0.90 SSTR5 (0.48) SSTR5KCNH2RARARARBPPARD
SCHEMBL20053541 0.89 SLC6A9 (0.41) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15538426 0.87 DYRK1A (0.43) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15539556 0.87 DYRK1A (0.43) SSTR5KCNH2PPARDFFAR4GPR119
SCHEMBL15538572 0.85 PIK3CA (0.41) GPR119RBP4SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 CHRM4 669/4885CHRM2 432/4885CHRM5 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.